ArticleERJ open research2026
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma Registry.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic disease in young adults is associated with poor healthcare engagement, poor health-related outcomes and high-risk behaviours. However, there are minimal data regarding the outcomes of young adults with severe asthma. In this study we aimed to assess asthma characteristics and outcomes in young adults aged 16-25 years compared to older age groups. Methods: Using the UK Severe Asthma Registry, we undertook a retrospective observational analysis comparing baseline assessment and annual follow-up data in young adults against other age groups. We investigated differences in medication use, healthcare utilisation, exacerbation rates, lung function, airway inflammation, quality of life and comorbidities using univariate and multivariable analysis. Results: Registry data from 2812 participants was included, including 236 (8.4%) young adults. This age group had the lowest levels of adherence and highest fractional exhaled nitric oxide, highest rates of emergency department attendance and hospitalisation, the second highest rate of intubation, and most frequently reported anxiety and depression. Data from the first annual review confirmed this age group still had the highest rate of emergency department attendance, hospitalisation and the smallest improvement in asthma control. Conclusion: In this cohort, young adults with severe asthma were at a higher risk of poor clinical outcomes when compared to other age groups. The higher rates of emergency treatment and admission and higher levels of airway inflammation suggest that they may experience more severe exacerbations, the reasons for which require further investigation. If a causative link is supported by further work, these findings suggest that age-specific management strategies should be explored towards improving clinical outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.